Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jacob Bernheim"'
Autor:
Himisha Beltran, Mark A. Rubin, Muhammad Asad, Olivier Elemento, Jacob Bernheim, Ankur Singh, Michael Sigouros, Loredana Puca, Matthew J. Mosquera, Cynthia Cheung, Rohan Bareja, Juan Miguel Mosquera, Varun V. Prabhu, Joshua E. Allen, M. Laura Martin
Following treatment with androgen receptor (AR) pathway inhibitors, ~20% of prostate cancer patients progress by shedding their dependence on AR. These tumors undergo epigenetic reprogramming turning castration-resistant prostate cancer adenocarcinom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cf1272ffe4bf0f5ae9ae89e7b9a18f9
Autor:
Matthew J. Mosquera, Sungwoong Kim, Rohan Bareja, Zhou Fang, Shuangyi Cai, Heng Pan, Muhammad Asad, Maria Laura Martin, Michael Sigouros, Florencia M. Rowdo, Sarah Ackermann, Jared Capuano, Jacob Bernheim, Cynthia Cheung, Ashley Doane, Nicholas Brady, Richa Singh, David S. Rickman, Varun Prabhu, Joshua E. Allen, Loredana Puca, Ahmet F. Coskun, Mark A. Rubin, Himisha Beltran, Juan Miguel Mosquera, Olivier Elemento, Ankur Singh
Publikováno v:
Advanced Materials. 34:2270014
Autor:
Michael Sigouros, Juan Miguel Mosquera, Maria Laura Martin, Muhammad Asad, Sungwoong Kim, Shuangyi Cai, Nicholas J. Brady, Jared Capuano, Richa Singh, Himisha Beltran, Joshua E. Allen, Ahmet F. Coskun, Heng Pan, Loredana Puca, Zhou Fang, Rohan Bareja, Olivier Elemento, David S. Rickman, Mark A. Rubin, Ankur Singh, Jacob Bernheim, Sarah Ackermann, Florencia M. Rowdo, Matthew J. Mosquera, Varun V. Prabhu, Ashley Doane, Cynthia Cheung
Publikováno v:
Adv Mater
Following treatment with androgen receptor (AR) pathway inhibitors, ∼20% of prostate cancer patients progress by shedding their AR dependence. These tumors undergo epigenetic reprogramming turning castration-resistant prostate cancer adenocarcinoma